A carregar...
Immunotherapies and Future Combination Strategies for Head and Neck Squamous Cell Carcinoma
Head and neck squamous cell carcinoma (HNSCC) is often diagnosed at an advanced stage and has a dismal prognosis. Nearly 10 years after the approval of cetuximab, anti-PD1/PD-L1 checkpoint inhibitors are the first drugs that have shown any survival benefit for the treatment on platinum-refractory re...
Na minha lista:
| Publicado no: | Int J Mol Sci |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
MDPI
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6862353/ https://ncbi.nlm.nih.gov/pubmed/31671550 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms20215399 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|